Trials / Unknown
UnknownNCT04805047
SodiUm Restriction by Behavioral Intervention
Sodium Restriction by Behavioral Intervention: Education and Monitoring
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 142 (estimated)
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University · Academic / Other
- Sex
- All
- Age
- 14 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the effects and efficacy of dietary sodium restriction by mean of a new healthcare approach in patients with immunoglobulin A nephropathy. The test persons in the intervention group are actively supported to adhere to a restricted sodium diet with a structured education program in combination with regular sodium excretion monitoring.
Detailed description
Patients in the intervention group receive regular sodium-restriction education by a dietician, which entails introducing food types and cooking skills, quantifying salt intake with a special spoon and recording detailed interactive food diary. Sodium excretion was measured using one 24-hour urine collection regularly to assess dietary compliance and enable feedback. The test persons with sodium excretion higher than 90mmol/24h will receive intensive education. Test persons in the control group receive standard care. After 2 weeks in study, all test persons visit the outpatient clinic for measurements and data collection. Within 3 months of total study duration, data collection and measurements take place at the end of every month. At each timepoint blood and 24-hourly urine is collected, test persons fill out questionnaires.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | education and monitoring | regular education programs supported by a dietician in combination with urine sodium monitoring as a feedback |
Timeline
- Start date
- 2021-05-15
- Primary completion
- 2023-05-01
- Completion
- 2023-12-01
- First posted
- 2021-03-18
- Last updated
- 2022-04-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04805047. Inclusion in this directory is not an endorsement.